Back to search

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

Data up to Jan 2025

Published2000
Citations282
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable… (2000) – Arthritis & Rheumatism | Metascience Observatory Explorer